Who knows PIP, maybe but not enough to gamble on in my opinion. I should have sold back in the 1.50's the day after the short list restriction. Hopefully they can pull something good out of the data but who knows. How did that miss so bad after a Phase II that was so successful apparently on worse off patients and risk factors. What are you going to do?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.